chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Felt lousy; Minor symptoms; Shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Felt lousy), VACCINATION COMPLICATION (Minor symptoms) and ARTHRALGIA (Shoulder pain) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013M20A and 027L20A) for COVID-19 vaccination.     Concurrent medical conditions included Heart attack (Reported as heart condition and he had two heart attacks and a stent placed.) and Diabetic.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-Feb-2021, the patient experienced MALAISE (Felt lousy), VACCINATION COMPLICATION (Minor symptoms) and ARTHRALGIA (Shoulder pain). At the time of the report, MALAISE (Felt lousy), VACCINATION COMPLICATION (Minor symptoms) and ARTHRALGIA (Shoulder pain) outcome was unknown.            It was reported that the patient had two heart attacks and a stent placed. No concomitant medications information were reported. No treatment medications were provided.
Reaction started about 90 min post immunization. Started with pain at injection site, patient had low grade fever an could not move arm. Redness noticed 10/7 and has spread down to elbow by 10/8. Area is hot, hard and red.
This spontaneous report was received from a registered pharmacist via a company representative concerning a patient of unknown age and gender. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date, dose and route unspecified). No concomitant therapy was reported. On an unknown date, after the vaccination, the patient experienced an unspecified rash. It was unspecified if the patient sought any medical attention. It was unspecified if any treatment was given or if any lab tests were performed. The outcome of unspecific rash was unknown. The relatedness for unspecific rash was unknown for ZOSTAVAX. Additional information has been requested.
Tightness in chest Very irregular heartbeats Feeling of "enlarged" heart muscle Can't breathe properly Lump in throat Burning sensation in chest Severe lack of stamina Being active causes intense heart pressure to the point of fainting Swelling at injection site  Symptoms started less than an hour after the first shot, still ongoing, getting worse  ER visit on day 3, no clear diagnosis, no treatments.  Still ongoing
A few hours later a migraine headache, not well feverish. Next morning jaw pain and unusual sensations on left side of face and body, arm and fingers is too. Very scared went to Dr Mon. gave antibiotics. Sat. Oct 4, ER tongue swelled couldn't breathe, took allergy pills and gave me more steroids. Saw physician Mon. Don't know why I am having reactions. 3 weeks later still having problems. Pain in arm and swelling of tongue. Tingling in face.
I have been taking Tylenol for my hip replacement that I had in Dec. I take Benadryl at night because we live in an old house./2 months ago I had my hip replaced; I have heaviness around my chest/heavy feeling in my chest; my blood pressure is extremely high./blood pressure go up after receiving the vaccine; I also feel out of breath.; headache/mild headache; This is a spontaneous report from a contactable consumer (patient herself). A 65-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EM9809), via an unspecified route of administration on 17Feb2021 (last Wednesday) (age at vaccination: 65 years) as DOSE 2, SINGLE for covid-19 immunisation. The patient's medical history included hip arthroplasty for which she was on advil 2 to 3 times a day, blood pressure abnormal (husband has blood pressure), spinal fusion surgery 4 months before, sneezing took Benadryl. Concomitant medication(s) included aspirin (acetylsalicylic acid), diazepam (VALIUM) 15mg in the morning and 15mg at night. The patient previously took tylenol and experienced abdominal discomfort and bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9263) on 27Jan2021 for covid-19 immunisation. On an unknown date, the patient had been taking tylenol for her hip replacement that she had in December2020, take benadryl at night because she lives in an old house, 2 months ago she had my hip replaced, have heaviness around my chest/heavy feeling in my chest (started 24 hours after), her blood pressure was extremely high./blood pressure go up after receiving the vaccine and she also felt out of breath. She didn't have any problem with my first shot. She barely even felt. On 19Feb2021 (2days after the vaccine), the patient experienced headache/mild headache, On an unknown date, the patient's blood pressure measurement was 158/118; blood pressure systolic was 100 (it's little over 100, for a couple of days). She cant take Tylenol as it upsets her stomach. She did not have a rash. She was severely allergic to it. The outcome of the events was unknown. There was no product quality complaint (PQC) present.  No follow-up attempts are possible. No further information is expected.
We had the COVID Moderna vaccine at Pharmacy. We do not know the series or lot number information.  Patient received only the Moderna. I received the Moderna & Flu.
Dermatome under her right breast, almost like post-herpetic neuraliga; Difficulty swallowing; Pruritis; This case was reported by a other health professional via call center representative and described the occurrence of post herpetic neuralgia in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In November 2018, the patient received the 2nd dose of Shingrix (intramuscular). On an unknown date, 10 days after receiving Shingrix, the patient experienced post herpetic neuralgia, swallowing difficult and pruritus. On an unknown date, the outcome of the post herpetic neuralgia, swallowing difficult and pruritus were unknown.   It was unknown if the reporter considered the post herpetic neuralgia, swallowing difficult and pruritus to be related to Shingrix.  Additional details were provided as follows: The reporter was veterinarian reported for his friend. About 10 days after vaccination with dose of Shingrix, the patient experienced prurities along a dermatome under her right breast, almost like post herpetic neuraliga. Less than 2 years after vaccination, the patient experienced some difficultly in swallowing. The patient was evaluated at medical center by neurologist but no formal diagnosis at this time.
I was fine when I went to bed. I woke up with violent chills, a fever, a headache and a sore arm. It lasted between 24 and 36 hours. Gradually dissolved. I am due any day now and my pregnancy has progressed well.   Pregnancy history: progressed well EDD: any day now Birth Weight: N/A
Information has been received from a pharmacist concerning a patient who was vaccinated with a dose of PNEUMOVAX 23 and experienced severe arm swelling. Its unknown if the patient has sought any medical attention. The pharmacist did not want to report this because she didn't administer the shot. This is one of several reports received from the same source. No further information is available.
Diagnosed at ER with vaccine related measles. Was broke out from head to toe. Her Dr. Said it wasn't because of shot, ER confirmed it was. Treatment: Anti-itch medicine, ibuprofen and Calamine lotion.
Couldn't put on sweater, warm to the touch, chills to the point that her teeth were chattering, still tender on top of left arm. Hasn't seen doctor or taken ASA.
I broke out all around my face, neck, torso, and arms and they were raised hives. My eyes burned and I was pretty miserable and drugged up for two weeks. This lasted altogether three months. I was on hydroxyzine 3x a day, Pepcid 2x a day, and xyzal 2x a day. After the two weeks I started backing off the hydroxyzine so that I could go back to work. The hives had gone away but my eyes still burned, like a chemical burning feeling and when I take a shower even in the warmest of water, I have purple spots where the hives were, but I only notice it in the shower. I seen my PCP and she said that it was a reaction to the the vaccine and I also seen a dermatologist and she said I was allergic to the polyethylene glycol in the vaccine and I went back to my PCP and she said she didn't think it was a reaction to that and she refused to see me and wouldn't give me a steroid shot and o I changed my PCP and my dermatologist was the one who put me on my medications.
Patient reported red mark - 2 inch that was warm to the touch and swollen 2 days after administration. No trouble breathing no itching.
Type I diabetes diagnosed on July 6, 2004.  My son has been on insulin for type I diabetes since then. 05/23/07-records received-note dor DOS 6/10/04-parent concerned regarding wet diapers and diabetes history in family. Hospital records for DOS 07/06/04-DX: New onset diabetes. servere diabetic ketoacidiosis resolved. Seen for increased labored breasthing. Respiratory rate in ED 58,HX ear infections last occurring beginning of June. After measles vaccine on 6/22/04-broke out in rash and parent felt breathing faster. 1/5/10 Patient still has type 1 diabetes.
Chronic fatigue. Suicide Sept 2002. MD was notified by a former squadrom member. Death due to carbon monoxide toxicity. Autopsy Report received on 7/09/2003 states overdose.
Received Pfizer vaccines on 1/29/21, 2/19/21, 10/20/21. Tested positive by  PCR for COVID 19 on 10/31/21 admitted to hospital on 10/31/21 d/t syncope, asymptomatic for COVID 19
More and more depressed; Other side effects; This spontaneous case was reported by a patient and describes the occurrence of DEPRESSION (More and more depressed) and ADVERSE DRUG REACTION (Other side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DEPRESSION (More and more depressed) and ADVERSE DRUG REACTION (Other side effects). At the time of the report, DEPRESSION (More and more depressed) and ADVERSE DRUG REACTION (Other side effects) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) dosing remained unchanged.       No concomitant medications were reported.  Reportedly, ever since The patient had first and second dose of the vaccine, the patient was becoming more and more depressed besides other side effects. Patient believed the vaccine was a reason for this. I The patient was going to look into this further since the patient never had mental illness or depression. If it is the Moderna vaccine patient would make them accountable. This was a rushed vaccine that should have bee studied further before releasing to the public. reported the patient.  Treatment information was not provided.   This case was linked to MOD-2021-073169 (Patient Link). o...
Clinical Summary Patient is a 79 y.o. male with a history of HTN, HLD, OSA, chronic pain syndrome, hypothyroidism, CKD 2, TIA who presented to hospital 11/26/2022 with shortness of breath. Labs in ED showed lactic acid 2.1, troponin 36, WBC 15.2, Cr 1.5. CXR showed bilateral basilar atelectasis. Patient was found to be in hypoxic respiratory failure and sepsis as well Afib w/ RVR. COVID-19 was positive.   1. Acute respiratory failure: w/ hypoxia. Secondary to COVID-19, superimposed bacterial pneumonia. Imaging as below. Required BiPAP initially in ED than transitioned to NRB. Improved to 11L oxymizer. Continued supplemental O2 as needed, weaned as tolerated. Incentive spirometry ordered, IV lasix for dry strategy (redosed 11/30). Was able to wean to 2L NC on 11/30. Qualified for home O2, cont to wean as outpatient.  2. Sepsis: met criteria on admission with tachycardia, leukocytosis, tachypnea, lactic acidosis. Suspected pulmonary source. S/p 30 cc/kg IVF. Abx as below. Blood cultures so far NGTD. Completed course for CAP.  3. COVID-19 pneumonia: symptom onset 5 days prior to admission. Vaccinated with booster. Positive test 11/26/22. Continued dexamethasone, remdesevir. Supportive care. Trended inflammatory markers- improved. Complete decadron course.  4. Superimposed bacterial pneumonia: On admission, WBC 15.2, procal 1.28. CT chest suggesting multifocal pneumonia. Atypical antigens negative. Continued rocephin. Stopped azithromycin. Completed course for Cap.  5. Atrial fibrillation w/ RVR: new diagnosis. In ED, HR noted 166. EKG showed Afib w/ RVR. Weaned off diltiazem GTT. Continued heparin GTT, transition to DOAC once more clinically stable. Continued PO metoprolol. Cardiology followed. Transition to eliquis on 11/30.  Follow up afib clinic.  6. Elevated troponins: Trops 9, 22, 36. EKG with no acute ischemic changes. No chest pain noted. ECHO 11/27/22 showed LVEF 62%, no WMA, pulmonary HTN. Suspected demand ischemia related to above, low suspicion for ACS. Continued metoprolol. Cardiology followed. 7. Lactic acidosis: secondary to sepsis. Lactic acid 2.1, 2.4, 2.6. S/p IVF. Resolved. 8. CKD 2: baseline Cr 1.1-1.3. Cr on admission 1.5. Monitored. 9. HTN: continued home amlodipine. Held home losartan with higher than baseline Cr. Restart as able. Monitored. 10. HLD: continued home statin. 11. Hypothyroidism: continued home levothyroxine 12. Chronic pain syndrome: Continued home suboxone. NARx reviewed 13. H/o TIA: per hx. Continued home statin
I was diagnosed with shingles and I took an anti-viral medicine - Valacyclovir  (I took that for one week) - that helped with the symptoms  - they are mostly gone now.
Trigeminal neuralgia, in addition: nausea, diarrhea, deterioration, malaise, cold.
Rash is itchy on the injection site; Rash on injection site, the size of a couple of quarters; Rash is raised on the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE PRURITUS (Rash is itchy on the injection site), VACCINATION SITE RASH (Rash on injection site, the size of a couple of quarters) and VACCINATION SITE SWELLING (Rash is raised on the injection site) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Rash is itchy on the injection site), VACCINATION SITE RASH (Rash on injection site, the size of a couple of quarters) and VACCINATION SITE SWELLING (Rash is raised on the injection site). At the time of the report, VACCINATION SITE PRURITUS (Rash is itchy on the injection site), VACCINATION SITE RASH (Rash on injection site, the size of a couple of quarters) and VACCINATION SITE SWELLING (Rash is raised on the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication included blood thinner. Treatment included ice pack.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
pt recvd vax; exp high fever, body aches; HA; extreme rash at inject site only;eyes sensitive to light;
101.7 F fever; A spontaneous report was received from a Nurse concerning herself, a female patient of an unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a fever of 101.7F/pyrexia.  The patient's medical history provided included Asthma. Relevant concomitant medication was reported which included Benralizumab.  On 22 Dec 2020, prior to the onset of symptoms, the patient received their doses of mRNA-1273 (lot/batch: 011J2A) for prophylaxis of COVID-19 infection.   On 22 Dec 2020, the patient, who was a COVID-19 IV nurse, experienced a fever of 101.7. The patient was feeling much better on 23 Dec 2020.  No treatment information was provided.   Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the event, 101.7 F fever, was resolving at the time of this report.   The reporter did not provide an assessment for the event of 101.7 F fever.  Follow-up received on 31 Jan 2021, 8:31 PM, included the current temperature of the patient which showed a temperature of 100° F. No additional information received.  Follow-up attempt initiated again.; Reporter's Comments: This case concerns a female patient who received their first of two planned doses of mRNA-1273 (Lot 011J2A), who experienced an expected event of fever. The event occurred the same day after the first dose of Moderna COVID-19 Vaccine administsration. The reporter did not provide the causality assessment for the event. The event of fever was considered related to Moderna COVID-19 Vaccine.
Clinical Summary PATIENT is a 91 y.o. male with a history of HTN, recent diagnosis COVID-19 at urgent care visit who presented to RMH 9/5/2023 as a trauma s/p mechanical fall. Found to have acute SDH, SAH, and hemorrhagic contusion requiring further care. Additionally developed acute hypoxia respiratory failure. Agency was consulted for geriatric evaluation, assumed care as primary on 9/7/23.   1. Acute SDH/SAH/Hemorrhagic Contusion with Cerebral Edema: Traumatic due to fall. Admit 9/5/23 with acute left subdural and subarachnoid hemorrhages with 8 mm left-to-right midline shift; acute cerebral hemorrhagic contusion in the right inferior temporal lobe. Repeat CTHs stable except for slightly increased rightward subfalcine herniation. NSG recommended NOM, OP follow up in 3-4 weeks for repeat CTH.  2. Fall: Pt went down to the basement for COVID-19 isolation, fell down the stairs, amnestic to event. Hit head with LOC. Injuries as discussed. TTE 9/7/23 with EF 69%, no WMA. Evaluated with EEG for 48hrs which did not reveal any seizures. 3. COVID-19 Infection: Patient with cough and congestion, tested positive for COVID-19 at urgent care 9/5/23. S/p 4 doses of Moderna. Admit CT chest 9/5/23 with nonspecific mild mosaic ground-glass attenuation of the lung parenchyma bilaterally. Initially had no need for O2 but later required so Decadron and Remdesivir initiated.  4. Acute Hypoxic Respiratory Failure: In setting of COVID-19. VBG niot obtained. CXR as discussed. Required up to 4L NC on admit, stable on 2L NC 9/7/23. Weaned off o2 by time of discharge. 5. Thrombocytopenia: Baseline Plt unknown. Admit Plt 168, down-trended to 119 on 9/6/23. In setting of illness/trauma.  6. Incidental Findings: Per admit imaging 9/5/23: Diverticulosis, prostatic enlargement, diffuse urinary bladder wall thickening consistent with chronic urinary bladder outlet obstruction, small bilateral fat-containing inguinal hernias, bilateral renal cysts. Asymptomatic. Recommend OP follow up.
Pain in hip when moves to stand, sit, or walk; Soreness at the injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 90-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 24th July 2022, the patient received the 2nd dose of Shingrix (intramuscular). On 24th July 2022, immediately after receiving Shingrix, the patient experienced injection site pain. On 25th July 2022, the patient experienced pain in hip. On an unknown date, the outcome of the injection site pain and pain in hip were recovering/resolving.   It was unknown if the reporter considered the injection site pain and pain in hip to be related to Shingrix.     Additional Information: GSK Receipt Date: 26-JUL-2022 Reporter's Comments: The reporter was the patient who reported that received her Shingrix vaccine on the right arm.  The patient reported that right after receiving the Shingrix vaccine, felt soreness at the injection site, which was normal for her.  The patient had began to experience pain in her right hip when she moves to stand, sit, or walk. The 1 day after receiving Shingrix, the patient experienced pain in hip.   The reporter was not sure if this was related to the Shingrix vaccine or not.  The patient reported the pain was a little better this morning.  The reporter did not consent to follow-up.  The caller did not give permission to contact HCP, since had not contacted him yet.  The caller would like to know if other patients had reported this to GlaxoSmithKline.
death J96.01 - Acute respiratory failure with hypoxia  I26.99 - Acute pulmonary embolism without acute cor pulmonale, unspecified pulmonary embolism type
C/o fatigue 5 minutes after receiving vaccine (FluMist) and "cloudy mentation". After 20 minutes observation Sx resolved. Vital signs stable throughout. Received FluMist 10:00 AM, c/o feeling fatigued after receiving FluMist. No numbness of tongue or lips, no CP, no SOB, no HA.
pt stated having rash covering her body and bruising extending down the arm the vaccine was administered in.
weight was 236-238 and bounces back and forth; Started getting real dizzy that comes and goes/ if she moves too fast that the dizziness comes and goes; Right arm is sore and not tender; This is a spontaneous report from a contactable consumer (patient). An 81-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EL3249 expiration date: May2021, via an unspecified route of administration on 26Jan2021 at a single dose in the right arm for COVID-19 immunization. Medical history included heart problem from Nov2019 and ongoing and angina pectoris. Concomitant medication included a lot of pills for her heart problem. She was on blood thinners, sugar pills, and uric acid because of the diuretics. The patient stated that she got her shot yesterday (26Jan2021) a little after 1. Later this morning (27Jan2021), that she started getting real dizzy that comes and goes. She was reading the list and dizziness was one of more serious side effects. She wanted to know what to do about it, it was one of things. She has another shot coming up on 16Jan (as reported). The patient further mentioned that her right arm was sore and not tender on 27Jan2021. If she moves too fast that the dizziness comes and goes. Her weight was 236-238 and bounces back and forth because she was on diuretics. The outcome of the events dizziness was not recovered, right arm was sore was recovering while for weight was 236-238 and bounces back and forth was unknown.
There was no adverse event. The wrong vaccine was given by mistake. She should have received the Moderna bivalent booster and instead was given the monovalent vaccine.
Pt received 3rd DTP at noon 18-JUL-90 approx 24 hrs later temp 103, episode of poor color, staring expression, hypotonia.  Twitching & color change cleared in seconds, hypotonia & expressionless face for minutes.  More details see WORM.
Fever at 8 am after receiving the vaccine; fever of up to 38.5 for 10 consecutive days in the evening, with severe headache, which improves with paracetamol
Our medical clinic refrigerators malfunctioned and created a too low temperature for vaccines to be viable. Patient received vaccination due to human error in not pulling the non-viable vaccines from refrigerator when it was reported that all non-viable vaccines were pulled correctly and transferred correctly. After speaking with all pharmaceutical companies regarding patient receiving non-viable vaccines, patient have been recalled and will received vaccine as soon as possible. Age of patient at time of event: 12 year 7 months.